Melanoma Surgery »  Research »  Clinical Trials
 
General Surgery Programs
Department of Surgery Websites

Melanoma Surgical Oncology

Michael D. Alvarado, M.D.
Assistant Professor of Surgery,
Division of General Surgery

About the program »

Melanoma Clinical Research

Adil I. Daud, M.D.
Professor of Medicine,
Department of Medicine,
Co-Director, UCSF Melanoma Center
Director, Melanoma Clinical Research

View Clinical Trials »

Genetic Analysis for Melanoma

Dermatologist Susana Ortiz-Urda, M.D. Ph.D., Co-Director of the UCSF Melanoma Center, discusses novel targeted agents to treat aggressive melanomas.

Hear the Interview »
 

Make a Gift

A gift to the Melanoma Program helps our physicians and scientists discover new
treatments and cures related to skin cancer.

 

How you can help »
Melanoma Surgery »  Research »  Clinical Trials

Clinical Trials

UCSF offers melanoma patients a broad menu of clinical trials, providing those eligible with access to some of the most promising novel agents and targeted therapies. Our clinical trials span various stages of melanoma, and include disease prevention, recurrence in high-risk surgical patients, and innovative drug therapies for patients with advanced metastatic melanoma.

Our principal investigators collaborate with melanoma researchers world-wide including the National Cancer Institute (NCI), cooperative inter-institutional research groups such as CALGB, ECOG, SWOG, ACSOG, and RTOG, and pharmaceutical companies to conduct clinical trials for the most promising therapies in melanoma.

   Also show trials not enrolling patients
Select by Type: 

Liver Metastases

Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Study ID: UCSF-08451-B
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Study ID: UCSF-08451-B
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients

Melanoma

A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
Study ID: UCSF-10854
Principal Investigator:
Adil I. Daud, M.D.
Enrolling patients
A Study of RO5185426 And GDC-0973 in Patients With BRAF-Mutation Positive Metastatic Melanoma
Study ID: UCSF-108510
Principal Investigator:
Adil I. Daud, M.D.
Enrolling patients
A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic Melanoma
Study ID: UCSF-10859
Principal Investigator:
Adil I. Daud, M.D.
Enrolling patients
A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma (CC# 10852)
Study ID: UCSF-10852
Principal Investigator:
Adil I. Daud, M.D.
Enrolling patients
Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212
Study ID: UCSF-10857
Principal Investigator:
Adil I. Daud, M.D.
Enrolling patients

Solid Tumor

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Study ID: UCSF-11993
Principal Investigator:
Hope Rugo, M.D.
Enrolling patients
Dose-Escalation Study of GSK2126458
Study ID: UCSF-09992
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
Study ID: UCSF-11996
Principal Investigator:
Hope Rugo, M.D.
Not yet enrolling
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
Study ID: UCSF-10998
Principal Investigator:
A. Jo Chien, M.D.
Enrolling patients
Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
Study ID: UCSF-09991
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Study ID: UCSF-11991
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Study ID: UCSF-11995
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Study ID: UCSF-10993
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
X